In vitro DNA modification by the ultimate carcinogen of 4-nitroquinoline-1-oxide: influence of superhelicity. 1989

P Menichini, and G Fronza, and S Tornaletti, and S Galiègue-Zouitina, and B Bailleul, and M H Loucheux-Lefebvre, and A Abbondandolo, and A M Pedrini
Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.

The effect of DNA tertiary structure on in vitro modification by 4-acetoxy-aminoquinoline-1-oxide (Ac-4-HAQO) was investigated. The reactivity of pAT153 plasmid DNA depended on the conformational state of the molecule: it progressively decreased according to the decrease of the superhelical tension, being negatively supercoiled DNA about two times more susceptible than singly-nicked relaxed DNA. HPLC of the three main Ac-4-HAQO adducts showed that 3-(deoxyguanosin-N2-yl)-4-aminoquinoline-1-oxide, N-(deoxyguanosin-C8-yl)-4-aminoquinoline-1-oxide and 3-(deoxyadenosin-N6-yl)-4-aminoquinoline-1-oxide accounted for 50, 25 and 10% of total quinoline DNA base adducts in all DNA conformations tested, except in the negatively supercoiled topoisomers where they accounted for 80, 15 and 5% respectively. DNA modification by Ac-4-HAQO resulted also in the formation of apurinic/apyrimidinic sites and in strand scissions. The quantification of these damages revealed that they represent an important fraction of all damaging events and that their yield is also influenced by DNA superstructure. Thus, these lesions must be considered as important DNA damage induced by Ac-4-HAQO.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009600 Nitroquinolines Quinolines substituted in any position by one or more nitro groups.
D009690 Nucleic Acid Conformation The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape. DNA Conformation,RNA Conformation,Conformation, DNA,Conformation, Nucleic Acid,Conformation, RNA,Conformations, DNA,Conformations, Nucleic Acid,Conformations, RNA,DNA Conformations,Nucleic Acid Conformations,RNA Conformations
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004264 DNA Topoisomerases, Type I DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix. DNA Nicking-Closing Protein,DNA Relaxing Enzyme,DNA Relaxing Protein,DNA Topoisomerase,DNA Topoisomerase I,DNA Topoisomerase III,DNA Topoisomerase III alpha,DNA Topoisomerase III beta,DNA Untwisting Enzyme,DNA Untwisting Protein,TOP3 Topoisomerase,TOP3alpha,TOPO IIIalpha,Topo III,Topoisomerase III,Topoisomerase III beta,Topoisomerase IIIalpha,Topoisomerase IIIbeta,DNA Nicking-Closing Proteins,DNA Relaxing Enzymes,DNA Type 1 Topoisomerase,DNA Untwisting Enzymes,DNA Untwisting Proteins,Topoisomerase I,Type I DNA Topoisomerase,III beta, Topoisomerase,III, DNA Topoisomerase,III, Topo,III, Topoisomerase,IIIalpha, TOPO,IIIalpha, Topoisomerase,IIIbeta, Topoisomerase,Topoisomerase III, DNA,Topoisomerase, TOP3,beta, Topoisomerase III
D004278 DNA, Superhelical Circular duplex DNA isolated from viruses, bacteria and mitochondria in supercoiled or supertwisted form. This superhelical DNA is endowed with free energy. During transcription, the magnitude of RNA initiation is proportional to the DNA superhelicity. DNA, Supercoiled,DNA, Supertwisted,Supercoiled DNA,Superhelical DNA,Supertwisted DNA
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Menichini, and G Fronza, and S Tornaletti, and S Galiègue-Zouitina, and B Bailleul, and M H Loucheux-Lefebvre, and A Abbondandolo, and A M Pedrini
January 1983, Carcinogenesis,
P Menichini, and G Fronza, and S Tornaletti, and S Galiègue-Zouitina, and B Bailleul, and M H Loucheux-Lefebvre, and A Abbondandolo, and A M Pedrini
November 1976, Nucleic acids research,
P Menichini, and G Fronza, and S Tornaletti, and S Galiègue-Zouitina, and B Bailleul, and M H Loucheux-Lefebvre, and A Abbondandolo, and A M Pedrini
May 1984, Analytical biochemistry,
P Menichini, and G Fronza, and S Tornaletti, and S Galiègue-Zouitina, and B Bailleul, and M H Loucheux-Lefebvre, and A Abbondandolo, and A M Pedrini
April 1986, Cancer research,
P Menichini, and G Fronza, and S Tornaletti, and S Galiègue-Zouitina, and B Bailleul, and M H Loucheux-Lefebvre, and A Abbondandolo, and A M Pedrini
October 1983, FEBS letters,
P Menichini, and G Fronza, and S Tornaletti, and S Galiègue-Zouitina, and B Bailleul, and M H Loucheux-Lefebvre, and A Abbondandolo, and A M Pedrini
January 1976, Advances in cancer research,
P Menichini, and G Fronza, and S Tornaletti, and S Galiègue-Zouitina, and B Bailleul, and M H Loucheux-Lefebvre, and A Abbondandolo, and A M Pedrini
February 1994, Nucleic acids research,
P Menichini, and G Fronza, and S Tornaletti, and S Galiègue-Zouitina, and B Bailleul, and M H Loucheux-Lefebvre, and A Abbondandolo, and A M Pedrini
October 1979, The Journal of general virology,
P Menichini, and G Fronza, and S Tornaletti, and S Galiègue-Zouitina, and B Bailleul, and M H Loucheux-Lefebvre, and A Abbondandolo, and A M Pedrini
April 1970, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
P Menichini, and G Fronza, and S Tornaletti, and S Galiègue-Zouitina, and B Bailleul, and M H Loucheux-Lefebvre, and A Abbondandolo, and A M Pedrini
December 1966, Science (New York, N.Y.),
Copied contents to your clipboard!